Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Barriers to Patient Enrollment Onto Frontline Therapeutic Clinical Trials and Development of Intervention Strategies to Increase the Proportion of Enrollment
Sponsor: Children's Oncology Group
A observational or N/A phase clinical study on Brain and Central Nervous System Tumors and Childhood Germ Cell Tumor, this trial is completed. The trial is conducted by Children's Oncology Group and has accumulated 6 data snapshots since 1992. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 1992
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Asheville, United States, Atlanta, United States, Burlington, United States, Charleston, United States, Charlotte, United States, Dallas, United States, Detroit, United States, Flint, United States, Gainesville, United States, Geneva, Switzerland and 19 more location s